๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin, doxorubicin and mitomycin in the treatment of diffuse malignant pleural mesothelioma (DMPM): A phase II fonicap trial

โœ Scribed by Pennucci, M.C.; Ardizzoni, A.; Mariani, G.L.; Giorgi, G.; Rao, F.; Rimoldi, R.; Fioretti, M.; Pronzato, P.; Testore, F.; Giordano, L.; Salvati, F.; Rosso, R.

Book ID
122603175
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
43 KB
Volume
11
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combined cisplatin, doxorubicin, and mit
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma : A Phase II FONICAP trial
โœ Maria Cristina Pennucci; Andrea Ardizzoni; Paolo Pronzato; Marina Fioretti; Clau ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 2 views

and cisplatin (P) yielded an objective response rate of 25% and a subjective response rate of 50% in patients with mesothelioma. In human mesothelioma cell